(Q41909152)

13 October 2017

Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro (English)

1 reference

13 October 2017

1 reference

1 reference

A A Weber

1

1 reference

13 October 2017

S Reimann

series ordinal

2

1 reference

13 October 2017

K Schrör

series ordinal

3

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

British Journal of Pharmacology

13 October 2017

1 reference

13 October 2017

126

1 reference

13 October 2017

415-420

1 reference

13 October 2017

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

13 October 2017

1 reference

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

Prostacyclin-dependent cyclic AMP formation in endothelial cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

Functionally thrombasthenic state in normal platelets following the administration of ticlopidine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

Direct inhibition of platelet function by organic nitrates via nitric oxide formation.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1565815

ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel

18 August 2018

1 reference

12 December 2020

Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel

1 reference

12 December 2020

Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine

1 reference

12 December 2020

The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A

1 reference

12 December 2020

cAMP is not an important messenger for ADP-induced platelet aggregation

1 reference

12 December 2020

Antiplatelet effect of ticlopidine after coronary stenting

1 reference

12 December 2020

Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel

1 reference

12 December 2020

Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel

1 reference

12 December 2020

Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP

1 reference

12 December 2020

Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits

1 reference

12 December 2020

Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin

1 reference

12 December 2020

Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJP.0702276

1 reference

13 October 2017

1 reference

13 October 2017

1 reference